Correlation between serum levels of interleukin-1β, interleukin- 1ra, interleukin-6, interleukin-10, interleukin 12, tumor necrosis factor-α and interferon-γ with some clinical and laboratory parameters in patients with salmonellosis

Biotechnology and Biotechnological Equipment

Volumn 19, Issue 1, 2005, Pages 143-146

  Stoycheva, M S ^a   Murdjeva, M A ^a  

^a UNIVERSITY HOSPITAL ST GEORGE   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; BACTERIAL VIRULENCE; BODY TEMPERATURE; CHLORIDE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ELECTROLYTE DISTURBANCE; GASTROINTESTINAL INFECTION; HOST CELL; HUMAN; IMMUNOCHEMISTRY; IMMUNOPATHOGENESIS; POTASSIUM BLOOD LEVEL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SALMONELLA; SALMONELLOSIS; SODIUM BLOOD LEVEL; TEMPERATURE DEPENDENCE;

BACTERIA (MICROORGANISMS); SALMONELLA;

EID: 13844280403     PISSN: 13102818     EISSN: None     Source Type: Journal    
DOI: 10.1080/13102818.2005.10817170     Document Type: Article

References (38)

1. Arai T., Hiromatsu K., Nishimura H., (1995) Immunology, 85, 381–388.
2. Astiz M., Rackow E., Still S., et al. (1995) Crit Care Med., 23, 9–17.
3. Bhutta A., Mansoorali N., Hussain R., (1997) J. Infect., 35, 253–256.
4. Bone R.C., (1995) Ann Intern Med., 115, 457–469.
5. Cieci-Woolwine F., Mc Dermoni P., Mizel S., (1999) Infect Immun., 67, 5176–5185.
6. Delves J.P., Roitt I., (2000) N. Engl. J. Med., 343, 37–117.
7. Dinarello C.A., (2000) N. Engl. J. Med., 181, 1055–1061.
8. Doefinger R., (1999) Allergy, 54, 409–412.
9. Finkelman F., Urban J., (2001) Allergy Clin. Immunol., 107, 772–779.
10. Garan J., (1999) Clin. Microbiol. Infect., 5, 2S 13–2S 15.
11. Guerrant R., Steiner T., Lima A., et al. (1999) J. Infect. Dis., 179, S 331–337.
12. Gulig P., Doyle T., Clare-Salzler M., et al. (1997) Infec. Immun., 65, 519–521.
13. Gupta S., (1998) Scand. J. Immunol, 48, 136–43.
14. Herendra de Silva M., Mendis L., Sheron N., et al. (1993) Gut, 34, 194–198.
15. Jung H., Eckman L., Yang S-K, et al. (1995) J. Clin. Invest., 95, 55–65.
16. Kucharzik T., (1998) Falk Symposium Abstracts, 110, October 16–17, 71–72.
17. Kuhn R., Lohler J., Pennick D., et al. (1993) Cell, 75, 263–274.
18. Mackay C., (2001) Nat. Immunol., 2, 95–101.
19. Marchant A., Deviere J., Byl B., et al. (1994) Lancet, 343, 707–708.
20. Meyer A., Noguchi Y., Ogle C., et al. (1994) Arch. Surg., 129, 1290–1295.
21. Mizuno Y., Takada H., Nomura A., et al. (2003) Clin. Exp. Immunol., 131, 111–117.
22. Ottenhoff T., Kumarratne D., Casanova J., (1998) Immunol Today, 19, 491–494.
23. Pashine A., Jons B., Rath S., et al. (1999) Inf. Immunol., 4, 481–489.
24. Pinsky M., Vincent J., Deviere J., (1993) Chest, 103, 565–575.
25. Raqib R., Wretling B., Andersson J., et al. (1995) J. Infect. Dis., 171, 376–384.
26. Rocha M., Maia M., Bezerra B., et al. (1997) Infect. Immun., 65, 2740–2746.
27. Skeen M., Miller M., Shinnick T., et al. (1996) J. Immunol., 156, 1196–1206.
28. Spellberg B., Edwards J., (2001) CID, 32, 76–102.
29. Stoycheva M., Murdjeva M., (2003) Biotechnol. & Biotechnol. Eq., 17, 120–123.
30. Utsunomiya I., Ito M., Ohishi S., (1998) Cytokine, 10, 956–963.
31. van Cott J., Staats H., Pascual D., (1996) J. Immunology, 156, 1504–1514.
32. van der Poll T., Sauder J., van Deventer H., et al. (1994) J. Infect. Dis., 169, 665–667.
33. van der Poll T., Jansen P., Montegut W., et al. (1997) J. Immunology, 158, 1971–1975.
34. van Ginkel F., Nguyen H., Mc Ghee J., (2000) Emerg. Inf. Dis., 6, 1–12.
35. Wenzel R., Pinsky M., Ulevitch R., et al. (1996) Clin. Infect. Dis., 22, 407–413.
36. Whitcup S., Rizzo L., Lai S., (2000) Eur. J. Immunol., 32, 989–993.
37. Wyant T., Tanner M., Sztein M., (1999) Infect. Immun., 67, 1338–1346.
38. Yin Z., Braun J., Braun L., et al. (1997) Arthritis Rheum., 40, 1788–1797.